As of 3:58pm ET
| +0.02 / +4.88%|
Perseon Corp. develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies. Its product line for cancer therapy has been created to offer hospitals and clinics a complete solution for thermal treatment of certain cancers as provided through microwave/RF systems. The company's product line includes a range of thermal systems for the treatment of certain cancers, including both hyperthermia and ablation treatment systems. Its hyperthermia cancer treatment systems are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. Its microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. The company was founded on March 17, 1978 and is headquartered in Salt Lake City, UT.
|Clinton E. Carnell||President, Chief Executive Officer & Director|
|William S. Barth||CFO, Secretary & Head-Investor Relations|
|Todd H. Turnlund||Vice President-Research & Development|
|Rick Gaykowski||VP-Regulatory, Quality & Clinical Affairs|
|Brian A. Meltzer||Chief Medical Officer & VP-Business Development|